© Wiley Periodicals, Inc.
Editor-in-Chief A. John Camm and Deputy Editor-in-Chief Christopher P. Cannon
Impact Factor: 2.586
ISI Journal Citation Reports © Ranking: 2014: 52/123 (Cardiac & Cardiovascular Systems)
Online ISSN: 1932-8737
Call for Trial Designs, Outcomes Research and Clinical Trial Updates
NOW ACCEPTING TRIAL DESIGNS and QUALITY AND OUTCOMES RESEARCH and CLINICAL TRIAL UPDATES
Submit your paper today!
About the NEW Clinical Trial Updates section
Deputy Section Editor: Deepak L. Bhatt, MD, MPH
Clinical Cardiology is the newest home for clinical trial updates research. The Clinical Trial Updates section was created to publish new analyses from cardiovascular clinical trials, including subgroup analyses or additional end points. We are targeting principal investigators and their colleagues for secondary or substudy trial analyses. Authors should place their trial data in the context of prior and ongoing trials and detail the clinical implications for today's practicing cardiologists. The Clinical Trial Updates section is meant to complement our existing Trial Designs and Quality & Outcomes sections of Clinical Cardiology. These existing sections are meant to support publication of methods/design submissions for large, ongoing studies, and original research articles focused on cardiology quality and outcomes research from registries, performance improvement programs, and other data sources, respectively. Manuscripts may be up to 3000 words and may include up to 40 references and 5 tables/figures. We welcome supporting information and slide sets that can be published online. We encourage you to contact the editors with submission queries or manuscript ideas. Of note, if authors have had peer reviews from a prior journal and wish to submit them with the manuscript, the editors can consider them and potentially expedite review and possible publication.
About the Trial Designs section
Deputy Section Editor: Robert P. Giugliano, MD, SM
The Trial Design section publishes trial rationale and design papers (also known as "methods papers") for large cardiovascular clinical trials and registries. Preference is given for large phase III randomized clinical trials, but the editors will consider well-designed registries and large phase II or phase IV studies. Authors should include the following sections:
1. Brief trial summary ( 300 words)
2. Introduction - discussion of the trial rationale and prior relevant data. Include the trial hypotheses and objectives.
3. Methods - trial design (please include a figure of the trial schema), entry criteria, and statistical section that describes the key endpoints, power/sample size calculation, and major analytic plan.
4. Discussion - place your trial in the context of prior and ongoing trials, and the implications for future practice.
Publication of baseline characteristics and baseline data are encouraged, but not required. Appendices that list the trial organization, including major committees, countries, core laboratories, etc. may also be included.
About the Quality and Outcomes section
Deputy Section Editor: Gregg Fonarow, MD
Quality and Outcomes section publishes original research articles focused on cardiology quality and outcomes research. The articles will include original research from registries, performance improvement programs, and other studies relevant to clinical decision making and patient centered outcomes research. Manuscripts are limited to 3,000 words, including figure legends. References are limited to 40 and are not counted in the word limit. There is a limit of no more than 5 figures and/or tables; additional figures/tables will publish online-only as supporting data. The is also the opportunity to publish accompanying slides sets as supporting materials.